ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1010

Catecholaminergic-to-Cholinergic Transition of Sympathetic Nerve Fibers in Arthritis and in a Co-Culture System of Sympathetic Ganglia in Vitro

Hubert Stangl1, Hans Robert Springorum2, Dominique Muschter2, Susanne Graessel2 and Rainer Straub3, 1Department of Internal Medicine 1, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, University Hospital Regensburg, Regensburg, Germany, 2Department of Orthopedic Surgery, Division of Experimental Orthopedic Surgery, University Hospital Regensburg, Regensburg, Germany, 3Internal Medicine, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, University Hospital Regensburg, Regensburg, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: bone biology, Catecholamines, cholinergic agonists and osteoclasts, Synovial Immune Biology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint: Cartilage, Synovium and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Sympathetic nerve fibers play an important role in bone and tissue homeostasis of joints. However sympathetic nerve fibers are able to switch their phenotype and respective neurotransmitter machinery from sympathetic to cholinergic. This transition was shown in developing sweat glands, in the periosteum and in failing heart tissue. This is crucial since strong anti-inflammatory effects have been described for the α7nicotinic acetylcholine receptor as well as for the cholinergic co-transmitter vasoactive intestinal peptide (VIP). We studied connective tissue obtained from the knee and finger joints of osteoarthritis (OA) and rheumatoid arthritis (RA) patients and tested possible transition requirements in an in-vitro model with murine sympathetic ganglia.

Methods: Knee synovial tissue samples obtained from 44 OA and 21 RA patients and connective as well as bone tissue samples from interphalangeal finger joints obtained from seven OA and five RA patients were stained for tyrosine hydroxylase (TH, noradrenergic fibers), vesicular acetylcholine transporter (VAChT, cholinergic fibers) and VIP (cholinergic fibers). Sympathetic ganglia were obtained from newborn C57Bl/6 mice and double-stained for TH and VAChT after a co-culture period of two days with osteoclast progenitors attained from the femoral and tibial bone marrow from adult healthy and arthritic mice. Supernatants from osteoclast progenitors were tested for possible transition factors. Whole RNA isolated from the respective osteoclast progenitors was screened via microarray analysis in order to identify possible candidate transition factors.

Results: In connective tissue sections from human finger joints, VAChT but not VIP positive cholinergic nerve fibers were more present in OA than in RA patients. In knee synovial tissue no significant difference in the appearance of cholinergic (VAChT and VIP) nerve fibers was found. The ratio of VAChT/TH immunoreactivity of sympathetic ganglia in coculture with osteoclast progenitors from healthy mice was elevated compared to experiments with osteoclast progenitors from arthritic mice. Leukemia inhibitory factor (LIF), a known transition factor from the glycoprotein 130 cytokine family, is present in low concentrations in supernatants from osteoclast progenitor cells but did not induce transition.  Microarray analysis showed an upregulation of several candidate molecules (biglycan, fibronectin, LIF, periostin, tenascin-C, tensin-1, TIMP-1) in the transcriptome of osteoclast progenitors from healthy mice compared to arthritic (n=3 vs. 3, mean fold chance >2.0, p<0.01).

Conclusion: In humans and mice, catecholaminergic-to-cholinergic transition is possible in less inflamed tissue of the joint but not in highly inflamed arthritic tissue.


Disclosure:

H. Stangl,
None;

H. R. Springorum,
None;

D. Muschter,
None;

S. Graessel,
None;

R. Straub,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/catecholaminergic-to-cholinergic-transition-of-sympathetic-nerve-fibers-in-arthritis-and-in-a-co-culture-system-of-sympathetic-ganglia-in-vitro/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology